Where The Buying Ran Strongest: 55 Small Cap Stocks At 52-Week Highs
A concentrated list of new market leaders raises questions about the quality of their recent runs.
Crinetics Pharmaceuticals (CRNX) has gained 143.4% over the last month, leading a list of 55 Small Cap stocks trading at their 52-week highs on Wednesday. The S&P 500, for context, returned +1.8% over the same period.
The day’s list is heavily weighted toward one industry, with 13 names from Regional Banks. This concentration raises a key question: are these new highs a sign of broad strength, or are they concentrated bets whose fundamentals demand a closer look? Below are the names hitting new highs.
The Complete 52-Week-High List
The table below shows the 10 largest of the 55 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| COLB | $9.5 Bil | 1.0% | 4.2% | 4.0% | 37.5% |
| MTCH | $9.4 Bil | 4.6% | 4.6% | 15.6% | 27.3% |
| APGE | $9.4 Bil | 0.2% | 0.8% | 52.0% | 245.4% |
| LTH | $9.3 Bil | 1.0% | 1.2% | 22.4% | 39.4% |
| GKOS | $9.1 Bil | 2.9% | 2.5% | 23.7% | 50.5% |
| FR | $8.7 Bil | 1.8% | 1.9% | 4.5% | 36.9% |
| CRNX | $8.7 Bil | 0.2% | 0.5% | 143.4% | 154.1% |
| JXN | $8.7 Bil | 1.9% | 14.7% | 14.3% | 45.9% |
| ETSY | $8.3 Bil | 3.2% | 11.1% | 23.4% | 48.6% |
| SYRE | $8.0 Bil | 3.2% | 7.0% | 26.3% | 522.0% |
Which names show the business is keeping pace with the stock price?
The two largest companies on the list tell different stories. Match (MTCH) has gained 15.6% over the last month and trades at 14.1 times trailing earnings. Its revenue grew 2.0% over the last twelve months, but it operates with a 28.1% operating margin.
Columbia Banking System (COLB), the largest name, saw its revenue grow 27.8% over the last twelve months. It trades at a similar 14.5 times trailing earnings, with a more modest one-month stock gain of 4.0%.
So how should I use a list like this?
A 52-week high is a sign of strength, and strong stocks often continue to perform. The price itself, however, tells you nothing about the value of the underlying business.
A disciplined investor treats this list not as a set of buy signals, but as a starting point for research. The essential work is to determine if the company’s financial performance justifies its new, higher price.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
One more pattern worth noticing: 22 of the 55 names are Financials stocks. When a whole group is making new highs together, a s&p regional banking ETF like KRE is one way to own the group’s strength without betting on which single name leads it from here.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.